BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8361137)

  • 1. Analgesic nephropathy in the 1990s--an Australian perspective.
    Nanra RS
    Kidney Int Suppl; 1993 Jul; 42():S86-92. PubMed ID: 8361137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium.
    Noels LM; Elseviers MM; de Broe ME
    Nephrol Dial Transplant; 1995; 10(2):167-74. PubMed ID: 7753450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analgesic nephropathy].
    Pintér I; Nagy J
    Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonsteroidal anti-inflammatory drugs--nephrotoxic mechanism of action].
    Sułowicz W; Stompór T; Tabor B
    Przegl Lek; 1999; 56(2):169-74. PubMed ID: 10375954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity of non-narcotic analgesics. At-risk patients and prescribing applications.
    Kincaid-Smith P
    Med Toxicol; 1986; 1 Suppl 1():14-22. PubMed ID: 3546999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic nephropathy.
    Mathew TH
    Aust Fam Physician; 1976 Apr; 5(3):314-23. PubMed ID: 8032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and abuse of analgesics in Nigeria: a community survey.
    Agaba EI; Agaba PA; Wigwe CM
    Niger J Med; 2004; 13(4):379-82. PubMed ID: 15523865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of terminal analgesics-induced nephropathy].
    Schwarz A; Pommer W; Kühn-Freitag G; Keller F; Molzahn M; Offermann G
    Schweiz Med Wochenschr; 1985 Jun; 115(23):790-5. PubMed ID: 3875149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic nephropathy and the use of nonsteroidal anti-inflammatory drugs in renal patients: new insight.
    Bennett WM; Porter GA
    J Nephrol; 1998; 11(2):70-5. PubMed ID: 9589376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study.
    Elseviers MM; Bosteels V; Cambier P; De Paepe M; Godon JP; Lins R; Lornoy W; Matthys E; Moeremans C; Roose R
    Nephrol Dial Transplant; 1992; 7(6):479-86. PubMed ID: 1320226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures.
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):41-6. PubMed ID: 8177475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
    Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
    Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is analgesic nephropathy still a problem in Belgium?
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1988; 3(2):143-9. PubMed ID: 3140080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic abuse in the elderly. Renal sequelae and management.
    Elseviers MM; De Broe ME
    Drugs Aging; 1998 May; 12(5):391-400. PubMed ID: 9606616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of analgetics nephropathy].
    Elseviers MM; De Broe ME
    Arch Belg; 1989; 47(1-4):77-80. PubMed ID: 2610578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity of patients with analgesic-associated nephropathy and end-stage renal failure.
    Schwarz A; Pommer W; Keller F; Kuehn-Freitag G; Offermann G; Molzahn M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():311-6. PubMed ID: 3991517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic nephropathy: an underestimated cause of end-stage renal disease.
    Drukker W; Schwarz A; Vanherweghem JL
    Int J Artif Organs; 1986 Jul; 9(4):219-46. PubMed ID: 3536758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.